Attitudes on pharmacogenetic testing in psychiatric patients with treatment-resistant depression.

Michael J McCarthyYucui ChenAnna DemodenaEileen FisherShahrokh GolshanTrisha Suppes John R Kelsoe

Published in: Depression and anxiety (2020)

These data indicate that while the overall risk is modest, some patients with depression may face psychosocial challenges in the context of pharmacogenetic testing. Future work should identify factors that predict distress and aim to tailor test results to different populations.

Keyphrases

mental health
depressive symptoms
sleep quality
big data
current status
deep learning
artificial intelligence